This effectiveness in patient care could contribute to a decrease in sensitivity of diagnostic markers, as recent studies have shown that maternal treatment during pregnancy reduced the sensitivity of IgM serological assays used to diagnose congenital toxoplasmosis in the neonate (12). This evidence concerns the gene CD40LG and congenital toxoplasmosis.